Related references
Note: Only part of the references are listed.Rescue of Synaptic Phenotypes and Spatial Memory in Young Fragile X Mice
Miao-Kun Sun et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Molecular regulation of synaptogenesis during associative learning and memory
Thomas J. Nelson et al.
BRAIN RESEARCH (2015)
ApoE4 and Aβ Oligomers Reduce BDNF Expression via HDAC Nuclear Translocation
Abhik Sen et al.
JOURNAL OF NEUROSCIENCE (2015)
Towards universal therapeutics for memory disorders
Miao-Kun Sun et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Identification of the PS1 Thr147Ile Variant in a Family with Very Early Onset Dementia and Expressive Aphasia
James Denvir et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Adduct formation in liquid chromatography-triple quadrupole mass spectrometric measurement of bryostatin 1
Thomas J. Nelson et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2014)
A Phase I Study of Temsirolimus and Bryostatin-1 in Patients With Metastatic Renal Cell Carcinoma and Soft Tissue Sarcoma
Elizabeth R. Plimack et al.
ONCOLOGIST (2014)
PKCε Promotes HuD-Mediated Neprilysin mRNA Stability NE and Enhances Neprilysin-Induced All Degradation in Brain Neurons
Chol Seung Lim et al.
PLOS ONE (2014)
Bryostatin-1 Restores Hippocampal Synapses and Spatial Learning and Memory in Adult Fragile X Mice
Miao-Kun Sun et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Cerebral ischemia-induced difference in sensitivity to depression and potential therapeutics in rats
Miao-Kun Sun et al.
BEHAVIOURAL PHARMACOLOGY (2013)
PKC activation during training restores mushroom spine synapses and memory in the aged rat
Jarin Hongpaisan et al.
NEUROBIOLOGY OF DISEASE (2013)
GDNF, NGF and BDNF as therapeutic options for neurodegeneration
Shelley J. Allen et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Bryostatin Improves Survival and Reduces Ischemic Brain Injury in Aged Rats After Acute Ischemic Stroke
Zhenjun Tan et al.
STROKE (2013)
Protein kinase C stimulates HuD-mediated mRNA stability and protein expression of neurotrophic factors and enhances dendritic maturation of hippocampal neurons in culture
Chol Seung Lim et al.
HIPPOCAMPUS (2012)
Phase II trial of bryostatin-1 in combination with cisplatin in patients with recurrent or persistent epithelial ovarian cancer: a California cancer consortium study
Robert J. Morgan et al.
INVESTIGATIONAL NEW DRUGS (2012)
Apolipoprotein E3 (ApoE3) but Not ApoE4 Protects against Synaptic Loss through Increased Expression of Protein Kinase Cε
Abhik Sen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
BRYOSTATIN-1 PROMOTES LONG-TERM POTENTIATION VIA ACTIVATION OF PKCα AND PKCε IN THE HIPPOCAMPUS
H. Kim et al.
NEUROSCIENCE (2012)
PKC ε Activation Prevents Synaptic Loss, Aβ Elevation, and Cognitive Deficits in Alzheimer's Disease Transgenic Mice
Jarin Hongpaisan et al.
JOURNAL OF NEUROSCIENCE (2011)
Protein Kinase C Activators as Synaptogenic and Memory Therapeutics
Miao-Kun Sun et al.
ARCHIV DER PHARMAZIE (2009)
Reduction of β-Amyloid Levels by Novel Protein Kinase Cε Activators
Thomas J. Nelson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Neuroprotective versus tumorigenic protein kinase C activators
T. J. Nelson et al.
TRENDS IN BIOCHEMICAL SCIENCES (2009)
Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer
Geoffrey Y. Ku et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Poststroke neuronal rescue and synaptogenesis mediated in vivo by protein kinase C in adult brains
Miao-Kun Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A structural basis for enhancement of long-term associative memory in single dendritic spines regulated by PKC
Jarin Hongpaisan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Phase I study of bryostatin 1 and gemcitabine
Basil F. El-Rayes et al.
CLINICAL CANCER RESEARCH (2006)
A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma
JA Ajani et al.
INVESTIGATIONAL NEW DRUGS (2006)
Bryostatin enhancement of memory in Hermissenda
A. M. Kuzirian et al.
BIOLOGICAL BULLETIN (2006)
A randomized phase II trial of interleukin-2 in combination with four different doses of bryostatin-1 in patients with renal cell carcinoma
AC Peterson et al.
INVESTIGATIONAL NEW DRUGS (2006)
Protein synthesis required for long-term memory is induced by PKC activation on days before associative learning
DL Alkon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Diacylglycerol-induced membrane targeting and activation of protein kinase Cε -: Mechanistic differences between protein kinases Cδ and Cε
RV Stahelin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Validation and implementation of a method for determination of bryostatin 1 in human plasma by using liquid chromatography/tandem mass spectrometry
M Zhao et al.
ANALYTICAL BIOCHEMISTRY (2005)
Identification of two distinct pathways of protein kinase Cα down-regulation in intestinal epithelial cells
OV Leontieva et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A multicentre phase II trial of bryostatin-1 in patients with advanced renal cancer
S Madhusudan et al.
BRITISH JOURNAL OF CANCER (2003)
A phase II study of bryostatin-1 and paclitaxel in patients with advanced non-small cell lung cancer
JD Winegarden et al.
LUNG CANCER (2003)
A phase II trial of bryostatin-1 in patients with metastatic or recurrent squamous cell carcinoma of the head and neck
DG Pfister et al.
INVESTIGATIONAL NEW DRUGS (2002)
Phase II evaluation of bryostatin-1 in metastatic melanoma
AY Bedikian et al.
MELANOMA RESEARCH (2001)
A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphoma
FH Blackhall et al.
BRITISH JOURNAL OF CANCER (2001)
Phase II study of bryostatin 1 in patients with relapsed multiple myeloma
ML Varterasian et al.
INVESTIGATIONAL NEW DRUGS (2001)
Share Paper
